Lupin Limited has informed the Exchange about press release dated 14-Apr-2022 titled Lupin Receives Approval from U.S. FDA for Desvenlafaxine Extended-Release Tablets 25 mg.
Lupin Limited has informed the Exchange about press release dated 14-Apr-2022 titled Lupin Receives Approval from U.S. FDA for Desvenlafaxine Extended-Release Tablets 25 mg.